Clinical Trial Update: Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating virtual reality and imaginal exposure with a cognitive enhancer for PTSD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Post Traumatic Stress Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-07-02